AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells-Reference-Cited by-同舟云学术

AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells

Published:2009-03 Issue:3 Volume:380 Page:699-704
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Zhao Wenhui,Zhang Qingyuan,Kang Xinmei,Jin Shi,Lou Changjie

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference25 articles.

1. Mechanisms of response and resistance to endocrine therapy for breast cancer and the development of new treatments;Howell;Rev. Endocr. Relat. Cancer,1993

2. Mechanisms of tamoxifen resistance;Osborne;Breast Cancer Res. Treat.,1994

3. Cellular and molecular pharmacology of antiestrogen action and resistance;Clarke;Pharmacol. Rev.,2001

4. Measurement of steroid hormone receptors in breast cancer patients on tamoxifen;Encarnacion;Breast Cancer Res. Treat.,1993

5. Changes in estrogen receptor, progesterone receptor, and pS2 expression in tamoxifen-resistant human breast cancer;Johnston;Cancer Res.,1995

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent strategies to overcome breast cancer resistance;Critical Reviews in Oncology/Hematology;2024-05

2. AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer;Frontiers in Endocrinology;2023-08-30

3. Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor;Oncogene;2023-06-17

4. Significant Association of Estrogen Receptor-β Isoforms and Coactivators in Breast Cancer Subtypes;Current Issues in Molecular Biology;2023-03-17

5. Nuclear Receptor Coregulators in Hormone-Dependent Cancers;Cancers;2022-05-13